Drug Type Mesenchymal stem cell therapy |
Synonyms- |
Target |
Action antagonists, inhibitors |
Mechanism CCR2 antagonists(C-C chemokine receptor type 2 antagonists), CXCR4 antagonists(C-X-C motif chemokine receptor 4 antagonists), PHB inhibitors(Prohibitin inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Inflammatory Bowel Diseases | Preclinical | South Korea | 25 Dec 2025 |





